OpenURL Connection Search

Select item for more details and to access through your institution.

Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial.
Published in:
British Journal of Haematology, 2015, v. 170, n. 4, p. 496, doi. 10.1111/bjh.13456
By:
- Goy, Andre;
- Kalayoglu Besisik, Sevgi;
- Drach, Johannes;
- Ramchandren, Radhakrishnan;
- Robertson, Michael J.;
- Avivi, Irit;
- Rowe, Jacob M.;
- Herbrecht, Raoul;
- Van Hoof, Achiel;
- Zhang, Lei;
- Cicero, Sherri;
- Fu, Tommy;
- Witzig, Thomas
Publication type:
Article
Outcomes in RBC transfusion-dependent patients with Low-/ Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study.
Published in:
European Journal of Haematology, 2014, v. 93, n. 5, p. 429, doi. 10.1111/ejh.12380
By:
- Giagounidis, Aristoteles;
- Mufti, Ghulam J.;
- Mittelman, Moshe;
- Sanz, Guillermo;
- Platzbecker, Uwe;
- Muus, Petra;
- Selleslag, Dominik;
- Beyne‐Rauzy, Odile;
- Boekhorst, Peter;
- Cañizo, Consuelo;
- Guerci‐Bresler, Agnès;
- Nilsson, Lars;
- Lübbert, Michael;
- Quesnel, Bruno;
- Ganser, Arnold;
- Bowen, David;
- Schlegelberger, Brigitte;
- Göhring, Gudrun;
- Fu, Tommy;
- Benettaib, Bouchra
Publication type:
Article
Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma.
Published in:
American Journal of Hematology, 2017, v. 92, n. 10, p. E575, doi. 10.1002/ajh.24854
By:
- Witzig, Thomas E.;
- Luigi Zinzani, Pier;
- Habermann, Thomas M.;
- Tuscano, Joseph M.;
- Drach, Johannes;
- Ramchandren, Radhakrishnan;
- Kalayoglu Besisik, Sevgi;
- Takeshita, Kenichi;
- Casadebaig Bravo, Marie-Laure;
- Zhang, Lei;
- Fu, Tommy;
- Goy, Andre
Publication type:
Article
The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project.
Published in:
Oncologist, 2017, v. 22, n. 12, p. 1415, doi. 10.1634/theoncologist.2017-0177
By:
- Sargent, Daniel J.;
- Shi, Qian;
- Flowers, Christopher R.;
- Schmitz, Norbert;
- Habermann, Thomas M.;
- Flament, Jocelyne;
- Fu, Tommy;
- Coiffier, Bertrand
Publication type:
Article
The distribution of cardiac diagnostic testing for acute coronary syndrome in the Brazilian healthcare system: A national geospatial evaluation of health access.
Published in:
PLoS ONE, 2019, v. 14, n. 01, p. 1, doi. 10.1371/journal.pone.0210502
By:
- Hertz, Julian T.;
- Fu, Tommy;
- Vissoci, Joao Ricardo;
- Rocha, Thiago Augusto Hernandes;
- Carvalho, Elias;
- Flanagan, Brendan;
- de Andrade, Luciano;
- Limkakeng, Alex T.;
- Staton, Catherine A.
Publication type:
Article

Found: 5

Longer-term follow-up and outcome by tumour cell proliferation rate (Ki-67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL-001(EMERGE) pivotal trial.

Outcomes in RBC transfusion-dependent patients with Low-/ Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study.

Long-term analysis of phase II studies of single-agent lenalidomide in relapsed/refractory mantle cell lymphoma.

The Search for Surrogate Endpoints in Trials in Diffuse Large B-Cell Lymphoma: The Surrogate Endpoints for Aggressive Lymphoma Project.

The distribution of cardiac diagnostic testing for acute coronary syndrome in the Brazilian healthcare system: A national geospatial evaluation of health access.